v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022 [1]   5,627,000      
Beginning balance at Dec. 31, 2022 $ 112,075 $ 1 $ 190,231 $ (77,418) $ (739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 1,987   1,987    
Issuance of common stock for vesting of restricted stock units (in shares) [1]   53,000      
Shares withheld related to net share settlement of stock-based awards (in shares) [1]   (19,000)      
Shares withheld related to net share settlement of stock-based awards (382)   (382)    
Net and comprehensive income (loss) (23,929)     (24,331) 402
Ending balance (in shares) at Mar. 31, 2023 [1]   5,661,000      
Ending balance at Mar. 31, 2023 89,751 $ 1 191,836 (101,749) (337)
Beginning balance (in shares) at Dec. 31, 2022 [1]   5,627,000      
Beginning balance at Dec. 31, 2022 112,075 $ 1 190,231 (77,418) (739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net and comprehensive income (loss) (47,226)        
Ending balance (in shares) at Jun. 30, 2023 [1]   5,826,000      
Ending balance at Jun. 30, 2023 69,260 $ 1 194,642 (125,327) (56)
Beginning balance (in shares) at Mar. 31, 2023 [1]   5,661,000      
Beginning balance at Mar. 31, 2023 89,751 $ 1 191,836 (101,749) (337)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options exercised (in shares) [1]   15,000      
Stock options exercised 7   7    
Stock based compensation expense 2,037   2,037    
Issuance of common stock for vesting of restricted stock units (in shares) [1]   62,000      
Shares withheld related to net share settlement of stock-based awards (in shares) [1]   (23,000)      
Shares withheld related to net share settlement of stock-based awards (374)   (374)    
Conversion of convertible notes (in shares) [1]   12,000      
Conversion of convertible notes 212   212    
Issuance of common stock for commitment shares under Standby Equity Purchase Agreement (in shares) [1]   99,000      
Issuance of common stock for commitment shares under the Standby Equity Purchase Agreement 924   924    
Net and comprehensive income (loss) (23,297)     (23,578) 281
Ending balance (in shares) at Jun. 30, 2023 [1]   5,826,000      
Ending balance at Jun. 30, 2023 $ 69,260 $ 1 194,642 (125,327) (56)
Beginning balance (in shares) at Dec. 31, 2023 5,941,000 5,941,000      
Beginning balance at Dec. 31, 2023 $ 45,196 $ 1 198,456 (153,261) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options exercised (in shares) 20,659 21,000      
Stock based compensation expense $ 1,968   1,968    
Issuance of common stock for vesting of restricted stock units (in shares)   30,000      
Shares withheld related to net share settlement of stock-based awards (in shares)   (14,000)      
Shares withheld related to net share settlement of stock-based awards (258)   (258)    
Issuance of common stock for ElectraMeccanica acquisition (in shares)   1,766,000      
Issuance of common stock for ElectraMeccanica acquisition 31,856   31,856    
Issuance of common stock for commitment shares under Standby Equity Purchase Agreement (in shares)   6,000      
Issuance of common stock for commitment shares under the Standby Equity Purchase Agreement 47   47    
Net and comprehensive income (loss) (11,003)     (11,003)  
Ending balance (in shares) at Mar. 31, 2024   7,750,000      
Ending balance at Mar. 31, 2024 $ 67,806 $ 1 232,069 (164,264) 0
Beginning balance (in shares) at Dec. 31, 2023 5,941,000 5,941,000      
Beginning balance at Dec. 31, 2023 $ 45,196 $ 1 198,456 (153,261) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net and comprehensive income (loss) $ (20,666)        
Ending balance (in shares) at Jun. 30, 2024 7,891,000 7,891,000      
Ending balance at Jun. 30, 2024 $ 59,224 $ 1 233,150 (173,927) 0
Beginning balance (in shares) at Mar. 31, 2024   7,750,000      
Beginning balance at Mar. 31, 2024 $ 67,806 $ 1 232,069 (164,264) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options exercised (in shares) 16        
Stock options exercised $ 10   10    
Stock based compensation expense 1,634   1,634    
Issuance of common stock for vesting of restricted stock units (in shares)   224,000      
Shares withheld related to net share settlement of stock-based awards (in shares)   (83,000)      
Shares withheld related to net share settlement of stock-based awards (563)   (563)    
Net and comprehensive income (loss) $ (9,663)     (9,663) 0
Ending balance (in shares) at Jun. 30, 2024 7,891,000 7,891,000      
Ending balance at Jun. 30, 2024 $ 59,224 $ 1 $ 233,150 $ (173,927) $ 0
[1] Shares have been retrospectively adjusted for the 1-for-30 reverse stock split that occurred on December 6, 2023.